Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?

Catherine R McGowan ORCID logo; Magdalena Harris ORCID logo; Lucy Platt ORCID logo; VivianHope; Tim Rhodes ORCID logo; (2018) Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it? The International journal on drug policy, 58. pp. 31-36. ISSN 0955-3959 DOI: 10.1016/j.drugpo.2018.04.017
Copy

Since 2013, North America has experienced a sharp increase in unintentional fatal overdoses: fentanyl, and its analogues, are believed to be primarily responsible. Currently, the most practical means for people who use drugs (PWUD) to avoid or mitigate risk of fentanyl-related overdose is to use drugs in the presence of someone who is in possession of, and experienced using, naloxone. Self-test strips which detect fentanyl, and some of its analogues, have been developed for off-label use allowing PWUD to test their drugs prior to consumption. We review the evidence on the off-label sensitivity and specificity of fentanyl test strips, and query whether the accuracy of fentanyl test strips might be mediated according to situated practices of use. We draw attention to the weak research evidence informing the use of fentanyl self-testing strips.



picture_as_pdf
Fentanyl-self-testing-outside-supervised-injection-settings-to-prevent-opioid-overdose.pdf
subject
Published Version
Available under Creative Commons: NC-ND 3.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: